Stock Taper 
GRFS
$7.69
▼ DOWN 1.66% (-0.13)
KEY STATISTICS
Market Cap$6.51 B
52w High$10.23
52w Low$6.96
Dividend Yield1.04%
FrequencyAnnual
P/E8.83
Volume322.33K
Shares Out.845.97M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Jose Ignacio Abia Buenache
ABOUT
SECTOR
Healthcare
WENT PUBLIC
June 2, 2011
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
25,258
UPCOMING EARNINGS
DateNov 10, 2026
DayTuesday
Rev. Est.$2.25B
NOV
10
TUE
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2016-01-04 | Forward | 2:1 |
| 2012-12-11 | Forward | 21:20 |
| 2012-07-23 | Reverse | 1:2 |
| 2011-12-01 | Forward | 11:10 |
PRICE
$7.69 ▼ DOWN 1.66% (−$0.13)About Grifols, S.A.
https://www.grifols.com ↗Grifols, S.A. is a Barcelona-based company specializing in plasma-derived medicines, medical supplies, diagnostics, and biological materials for healthcare and research worldwide.
INDUSTRY
Drug Manufacturers - General
A PRODUCT GRIFOLS, S.A. IS KNOWN FOR
FESILTYTM
FESILTYTM, FDA-approved in December 2025 and developed by Biotest (Grifols Group), is a purified fibrinogen concentrate for rapid treatment of acute bleeding in congenital fibrinogen deficiency, launching in the U.S. in early 2026.
Revenue by Products
| Icon | PRODUCT | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
 | Haemoderivatives | $3.81B | $5.01B ▲ | $5.56B ▲ | $6.49B ▲ |
 | Transfusional medicine | $712.24M | $640.6M ▼ | $648.48M ▲ | $623M ▼ |
 | Other Product | $39.62M | $250.16M ▲ | $203.45M ▼ | $243M ▲ |
 | Bio supplies | $225.76M | $146.08M ▼ | $159.96M ▲ | $154M ▼ |
 | Hospital supplies | $70.22M | — | — | — |
 | Fluid therapy and nutrition | $46.67M | — | — | — |
 | Other diagnostic | $23.63M | $21.74M ▼ | $21.79M ▲ | $17M ▼ |
Revenue by Geography
| Map | REGION | FY2021 | FY2022 | FY2023 | FY2025 |
|---|---|---|---|---|---|
 | USA and Canada | $3.15B | $3.86B ▲ | $3.9B ▲ | $4.25B ▲ |
 | Rest of the World | $872.12M | $1.18B ▲ | $1.44B ▲ | $1.66B ▲ |
 | Rest of European Union | — | — | — | $1.2B |
 | European Union | $544.04M | $711.58M ▲ | $893.05M ▲ | — |
 | SPAIN | $362.41M | $320.63M ▼ | $362.88M ▲ | — |
ETFS HOLDING THIS STOCK
ETFS HOLDING
18
LISTED HERE
8
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
16.31%
HOLDERS
311
TOP 12 OF 311 · RANKED BY POSITION SIZE
Brandes Investment Partners, LP
Capital World Investors
Permian Investment Partners, LP
Black Creek Investment Management Inc.
Pictet Asset Management Ltd
Armistice Capital, LLC
Millennium Management LLC
Bank Of America Corp /De/
Pictet Asset Management SA
Bank Of Montreal /Can/
Flat Footed LLC
Janus Henderson Group Plc
RATINGS SNAPSHOT
Overall rating: A-
Discounted Cash Flow4
Return On Equity4
Return On Assets4
Debt To Equity1
Price To Earnings3
Price To Book4
Overall Score4
TRADES BY CONGRESS
HOUSE TRADES
Daniel Goldman
Sale (Full)
2023-03-31
Greg Gianforte
Sale (Full)
2019-11-11
Donna Shalala
Sale (Full)
2019-06-24
MOST RECENT ANALYST GRADES
GRADE SUMMARY
NEUTRAL 1
1 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 HALO | $105.35 | COMPARE |
 CORT | $113.88 | COMPARE |
 DVA | $180.68 | COMPARE |
 GMED | $82.97 | COMPARE |
 MOH | $200.00 | COMPARE |
 BIO | $387.70 | COMPARE |
 HSIC | $89.52 | COMPARE |
 AVTR | $14.58 | COMPARE |